CTHRC1 Is Associated With BRAF(V600E) Mutation and Correlates With Prognosis, Immune Cell Infiltration, and Drug Resistance in Colon Cancer, Thyroid Cancer, and Melanoma. Biomol Biomed 2024. https://doi.org/10.17305/bb.2024.10397.